being carriers for haemophilia B. Two further intragenic RFLPs, F9(VIII)/XmnI) and F9(XIII)/DdeI, have been applied to this population and by using all three polymorphisms the carrier status could be determined in 68% of females at risk. Linkage disequilibrium was apparent between these three RFLPs, and The usefulness of each RFLP is less than predicted due to linkage disequilibrium betweeii these three polymorphisms within the factor IX gene. Table 4 compares the observed intragenic RFLP haplotypes in 31 normal X chromosomes with the numbers expected assuming random association on the basis of population fragment frequencies. Thus, two-thirds of normal factor IX genes studied had 1 3-11-5-1 7, 13-115-175 NT=not tested. The intragenic factor IX haplotypes associated with the disease mutation in each family are: pedigree 1756, 1-3/11-5/1-7; 2377, 1-3/11-5/1-7; 3569, 1-3/11-5/1-7; 4542, 1-3/11-5/1-7; 4549, 1-3/6-5/1-7; 4551, 1-8/11-5/1-7; 4555, 1-3/11-5/1-7; 4559, 1-8/11-5/1-7; 4565, 1-8/11-5/1-7; and 5215, 1-8/11-5/1-7. The RFLP order is as in the 
